266 related articles for article (PubMed ID: 14762666)
1. High-dose-rate interstitial brachytherapy for the treatment of penile carcinoma.
Petera J; Odrázka K; Zouhar M; Bedrosová J; Dolezel M
Strahlenther Onkol; 2004 Feb; 180(2):123-5. PubMed ID: 14762666
[TBL] [Abstract][Full Text] [Related]
2. High-dose rate brachytherapy in the treatment of penile carcinoma--first experience.
Petera J; Sirák I; Kašaová L; Mačingová Z; Paluska P; Zouhar M; Kutílek P; Brod'ák M; Vošmik M
Brachytherapy; 2011; 10(2):136-40. PubMed ID: 20702142
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).
de Crevoisier R; Slimane K; Sanfilippo N; Bossi A; Albano M; Dumas I; Wibault P; Fizazi K; Gerbaulet A; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1150-6. PubMed ID: 19395183
[TBL] [Abstract][Full Text] [Related]
4. Penile brachytherapy: results for 49 patients.
Crook JM; Jezioranski J; Grimard L; Esche B; Pond G
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):460-7. PubMed ID: 15890588
[TBL] [Abstract][Full Text] [Related]
5. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
6. High-dose-rate interstitial brachytherapy for T1-T2-stage penile carcinoma: short-term results.
Sharma DN; Joshi NP; Gandhi AK; Haresh KP; Gupta S; Julka PK; Rath GK
Brachytherapy; 2014; 13(5):481-7. PubMed ID: 25037912
[TBL] [Abstract][Full Text] [Related]
7. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
8. Penile brachytherapy: technical aspects and postimplant issues.
Crook J; Jezioranski J; Cygler JE
Brachytherapy; 2010; 9(2):151-8. PubMed ID: 19854685
[TBL] [Abstract][Full Text] [Related]
9. [Brachytherapy of cancer of the penis. Analysis of a series of 53 cases].
Suchaud JP; Kantor G; Richaud P; Mage P; Lamarche P; Dilhuydy JM; Pigneux J
J Urol (Paris); 1989; 95(1):27-31. PubMed ID: 2732482
[TBL] [Abstract][Full Text] [Related]
10. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
11. The role of radiation therapy after incomplete resection of penile cancer.
Langsenlehner T; Mayer R; Quehenberger F; Prettenhofer U; Langsenlehner U; Pummer K; Kapp KS
Strahlenther Onkol; 2008 Jul; 184(7):359-63. PubMed ID: 19016034
[TBL] [Abstract][Full Text] [Related]
12. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
[TBL] [Abstract][Full Text] [Related]
13. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
15. Accelerated partial-breast irradiation with interstitial implants: the clinical relevance of the calculation of skin doses.
Ott OJ; Lotter M; Sauer R; Strnad V
Strahlenther Onkol; 2007 Aug; 183(8):426-31. PubMed ID: 17680222
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients.
Nose T; Koizumi M; Nishiyama K
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):983-91. PubMed ID: 15234031
[TBL] [Abstract][Full Text] [Related]
17. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
18. Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate?
Nose T; Peiffert D; Lapeyre M; Hoffstetter S; Koizumi M; Nishiyama K
Strahlenther Onkol; 2004 Dec; 180(12):776-82. PubMed ID: 15592697
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
[TBL] [Abstract][Full Text] [Related]
20. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
